Neuraxis inc. issues letter to shareholders

Carmel, ind., jan. 13, 2025 (globe newswire) -- neuraxis, inc. (“neuraxis,” or the “company”) (nyse american: nrxs), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced that ceo brian carrico has published a letter to shareholders highlighting the company's achievements in 2024 and vision for 2025.
NRXS Ratings Summary
NRXS Quant Ranking